J. Craig Nelson, MD

Original Research

Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2006

James W. Jefferson, A. John Rush, J. Craig Nelson, et al

Original Research

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

November 15, 2005

J. Craig Nelson, Laura Portera, Andrew C. Leon

ASCP Corner

Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do?

August 15, 2005

J. Craig Nelson

Article

Managing Treatment-Resistant Major Depression

January 1, 2003

J. Craig Nelson

Article

Managing Treatment-Resistant Major Depression

January 1, 2003

J. Craig Nelson

Article

Diagnosing and Treating Depression in the Elderly

January 11, 2001

J. Craig Nelson

Article

Augmentation Strategies in Depression 2000

February 28, 2000

J. Craig Nelson

Original Research

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

April 30, 1999

Robert B. Ostroff, J. Craig Nelson

Original Research

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

March 31, 1999

M. Lynn Crismon, Madhukar Trivedi, Teresa A. Pigott, et al

Article

Augmentation Strategies With Serotonergic-Noradrenergic Combinations

September 1, 1998

J. Craig Nelson

Article

Treatment of Antidepressant Nonresponders: Augmentation or Switch?

June 1, 1998

J. Craig Nelson

Article

Overcoming Treatment Resistance in Depression

March 1, 1998

J. Craig Nelson

Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do?

Managing Treatment-Resistant Major Depression

Managing Treatment-Resistant Major Depression

Diagnosing and Treating Depression in the Elderly

Augmentation Strategies in Depression 2000

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Augmentation Strategies With Serotonergic-Noradrenergic Combinations

Treatment of Antidepressant Nonresponders: Augmentation or Switch?

Overcoming Treatment Resistance in Depression

ELSEWHERE:

FOLLOW US:

J. Craig Nelson, MD

Extended-Release Bupropion for Patients With Major Depressive Disorder Presenting With Symptoms of Reduced Energy, Pleasure, and Interest: Findings From a Randomized, Double-Blind, Placebo-Controlled Study

Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine

Increased Risk of Cerebrovascular Adverse Events and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: What's a Clinician to Do?

Managing Treatment-Resistant Major Depression

Managing Treatment-Resistant Major Depression

Diagnosing and Treating Depression in the Elderly

Augmentation Strategies in Depression 2000

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Augmentation Strategies With Serotonergic-Noradrenergic Combinations

Treatment of Antidepressant Nonresponders: Augmentation or Switch?

Overcoming Treatment Resistance in Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles